Glooko Wins “Best Overall MedTech Software” in 2026 MedTech Breakthrough Awards

Award recognizes Glooko's software portfolio supporting diabetes and glycemic management across outpatient care, inpatient glycemic management, regional remote monitoring, and patient self-management

PALO ALTO, Calif., May 7, 2026 - Glooko, Inc., a global digital health company focused on helping clinicians address the growing challenges of diabetes management and glycemic safety across the care continuum, today announced it has been selected as the winner of the "Best Overall MedTech Software" award in the 10th annual MedTech Breakthrough Awards program.

The recognition encompasses Glooko's suite of software solutions, including the Glooko diabetes management platform, EndoTool® Glucose Management System, Glooko XT, and the Glooko Mobile App. Together, the portfolio reflects Glooko's focus on simplifying diabetes and glycemic management for healthcare providers, hospitals and health systems, and people living with diabetes.

"This award reflects what the Glooko team is building every day: software that helps make diabetes and glycemic management simpler, more connected, and more actionable across the care continuum," said Mike Alvarez, Chief Executive Officer of Glooko. "From the Glooko platform and patient mobile app to Glooko XT in France and EndoTool for inpatient glycemic management, our portfolio is designed around the realities of care teams and people living with diabetes. We are honored by this recognition and energized to continue advancing connected care that improves workflows, supports safer decisions, and helps deliver better outcomes."

Glooko's diabetes management platform helps clinicians aggregate and visualize diabetes data from more than 200 diabetes and health monitoring devices and apps, with EHR integrations designed to reduce workflow friction and support more informed care conversations. The Glooko Mobile App helps people living with diabetes sync, view, and share health data with their care teams between appointments.

Glooko XT, the company's remote patient monitoring solution in France, is tailored for the French healthcare landscape and designed to support secure diabetes data monitoring and communication between persons with diabetes and their trusted healthcare providers.

EndoTool, developed and marketed by Monarch Medical Technologies, a Glooko Company, supports inpatient glycemic management through software designed to assist clinicians in optimizing insulin dosing for hospitalized patients.

Now celebrating its 10th anniversary, the MedTech Breakthrough Awards program has spent a decade recognizing the companies driving meaningful progress and improving patient care across the global health and medical technology industry. The program spans a wide range of categories - including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices and beyond - honoring the innovations reshaping how care is delivered worldwide.

This year's program drew a record-breaking number of nominations from leading companies and startups across more than 20 countries, reflecting the growing global impact and momentum of the digital healthcare industry.

"Glooko delivers a cohesive, scalable and clinically meaningful set of tools that support the entire patient journey," said Steve Johansson, managing director, MedTech Breakthrough. "Glooko's solutions create a care ecosystem that improves clinical workflows, enhances data accessibility and streamlines the patient journey. By partnering with diabetes device makers, pharmaceutical companies, and digital health innovators, Glooko continues to improve diabetes care and management."

About Glooko

Glooko is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. Glooko is uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings.

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

Not all products are available in all countries. EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko's diabetes management platform and EndoTool are currently independent solutions.

###

Media Contact
Julia Fuller
Vice President, Corporate Communications & Brand, Glooko
[email protected]